Parameter
| Biomarker | KLK13 | Full name | Kallikrein-related peptidase 13 | Molecular Type | Proteins |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis and disease progression monitoring | ||
| Disease | Esophageal Carcinoma | Disease Subtypes | / | ||
| Organ | Esophagus | Test Sample / Technology Platform | Tissue (IHC, qPCR) | ||
| Pathobiological Mechanisms | It belongs to the serine protease family and participates in the proteolytic process of tumorigenesis. Its high expression is related to the tumor progression, advanced stage and poor prognosis of ESCC, and its expression change can predict disease progression | ||||
| Clinical Availability Status | Clinical study phase: multiple clinical cohorts were used to verify its correlation with ESCC prognosis | ||||
| Notes and Dynamics | It can be used as a unique molecule to monitor the progression of ESCC, and its regulatory mechanism and targeting strategy deserve further exploration | ||||